Kappa

Independent Women's Law Center Joins the Fight to Keep Sororities Female

Retrieved on: 
Monday, September 25, 2023

WASHINGTON, Sept. 25, 2023 /PRNewswire/ --  Independent Women's Forum and Independent Women's Law Center (IWLC) are supporting the appeal of Kappa Kappa Gamma sorority women who were denied the all-female sisterhood they were promised. On Monday, the plaintiff sorority members in Westenbroek v. Kappa Kappa Gamma filed a notice to appeal in the District of Wyoming, which moves the case to the Tenth Circuit Court of Appeals. The Wyoming court ruled that the plaintiff sorority members were not entitled to a women's-only sorority, even though Kappa Kappa Gamma's bylaws require a women's only sorority, because the word "woman" is subject to interpretation.

Key Points: 
  • "With their support, we can continue to fight for the women that deserve respect in the present and in the future."
  • Sororities were founded to provide a single-sex space for women, and Kappa Kappa Gamma's board members cannot eliminate that promise simply by redefining the word.
  • "Independent Women's Law Center will always fight for women when those in power warp the English language to remove the same opportunities that have benefited women for decades," said Independent Women's Law Center attorney appealing the case, May Mailman.
  • Over the decades, sororities have heralded the benefits and values of a single sex environment to develop women's life and leadership skills.

Valmet to supply key pulp and paper technologies to Naini Papers in India

Retrieved on: 
Thursday, August 31, 2023

ESPOO, Finland, Aug. 31, 2023 /PRNewswire/ -- Valmet will deliver key technologies, automation and services to Naini Papers' cooking and fiberline rebuild and new specialty paper machine PM 3 at their mill in Kashipur, India. The delivery will increase the mill's capacity and support meeting the market demand of specialty coated paper. The delivery is scheduled for the first quarter 2025. 

Key Points: 
  • "We have been successfully collaborating with Valmet in many projects, including pulp mills, and decided to choose them again for this rebuild expanding our pulp production capacity.
  • The paper produced by the PM 3 can replace plastics in packages," says Pawan Agarwal, Managing Director, Naini Papers Limited.
  • Naini Papers Limited, founded in 1995, is one of the few premier paper manufacturing companies in India.
  • Valmet is a leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries.

Balchem Corporation Reports Second Quarter Sales of $231.3 Million, with Net Earnings of $30.1 Million, GAAP EPS of $0.93, and Adjusted EPS of $1.06

Retrieved on: 
Friday, July 28, 2023

Financial Results for the Second Quarter of 2023:

Key Points: 
  • Financial Results for the Second Quarter of 2023:
    The Human Nutrition & Health segment generated quarterly sales of $135.7 million, an increase of $4.0 million, or 3.1%, compared to the prior year quarter.
  • The Animal Nutrition & Health segment generated quarterly sales of $61.3 million, a decrease of $1.3 million, or 2.0%, compared to the prior year quarter.
  • The decrease was driven by lower sales in monogastric markets, partially offset by higher sales in the ruminant species markets.
  • Sales and production of products outside of our reportable segments and other minor business activities are included in "Other and Unallocated."

Asset Entities Raises the Bar for Sportswear Entering into AE.360.DDM Agreement with Iconic Apparel Brand Kappa USA to Design, Develop, and Manage their Discord

Retrieved on: 
Wednesday, July 12, 2023

Kappa USA’s AE.360.DDM Discord platform is already in the Design and Development stage at Asset Entities and is expected to launch this month.

Key Points: 
  • Kappa USA’s AE.360.DDM Discord platform is already in the Design and Development stage at Asset Entities and is expected to launch this month.
  • "Our agreement with Kappa USA is a match made in heaven.
  • “Kappa USA has always been on the cutting edge of style and is a deeply influential brand at the forefront of our culture.
  • Kappa USA is the American division of the Italian sportswear brand Kappa, founded in Turin, Italy, in 1967.

THE LEGEND CONTINUES… New York City's Iconic Fashion Retailer, Century 21 Re-Opens Tomorrow at its Flagship Location

Retrieved on: 
Monday, May 15, 2023

Tomorrow - May 16, 2023 -  The beloved retailer and purveyor of off-price luxury fashion is re-opening the doors of its flagship location in Manhattan's Financial District at 22 Cortlandt Street, with the support of experiences company LEGENDS.

Key Points: 
  • Tomorrow - May 16, 2023 -  The beloved retailer and purveyor of off-price luxury fashion is re-opening the doors of its flagship location in Manhattan's Financial District at 22 Cortlandt Street, with the support of experiences company LEGENDS.
  • New Yorkers and tourists in-the-know can now re-discover the thrill of "the hunt" as they shop luxury fashion at Century 21's head-turning prices.
  • The re-opened Cortlandt Street location houses the four main floors of the original space, with an intentional focus on Century 21's core business - fashion.
  • In celebration, Century 21 tapped NYC-based artist Timothy Goodman to create three  larger than life murals using objects and words that accentuate Century 21's place in NYC''s fashion scene.

Balchem Corporation Reports Record First Quarter Sales of $232.5 Million, with Net Earnings of $22.7 Million, GAAP EPS of $0.70, and Adjusted EPS of $0.94

Retrieved on: 
Friday, April 28, 2023

Sequentially, compared with the fourth quarter of 2022, sales increased 1.7% in the first quarter of 2023 and adjusted earnings from operations increased 14.1%.

Key Points: 
  • Sequentially, compared with the fourth quarter of 2022, sales increased 1.7% in the first quarter of 2023 and adjusted earnings from operations increased 14.1%.
  • The Animal Nutrition & Health segment generated quarterly sales of $64.9 million, a decrease of $4.5 million, or 6.4%, compared to the prior year quarter.
  • Sequentially, compared with the fourth quarter of 2022, sales and adjusted earnings were essentially flat in the first quarter of 2023.
  • Sequentially, compared with the fourth quarter of 2022, sales increased 1.3% in the first quarter of 2023 and adjusted earnings from operations were essentially flat.

Clario, GI Reviewers and RSIP Vision Team Up to Present a New AI Solution to Advance Clinical Trials for Inflammatory Bowel Diseases

Retrieved on: 
Monday, March 6, 2023

PHILADELPHIA and COPENHAGEN, Denmark and SAN MATEO, Calif. and BOSTON and JERUSALEM, March 6, 2023 /PRNewswire/ -- Clario, a leading healthcare research and technology company that generates the richest clinical evidence for the clinical trials industry and GI Reviewers, LLC Gastroenterology consultants and central readers, together with RSIP Vision, an experienced developer of groundbreaking AI technologies for medical imaging, today announced their new AI-based scoring system for inflammatory bowel diseases. The solution is expected to improve the reproducibility of colonoscopy video scoring, optimize workflow by shortening the time required for a human expert reader to score, and ultimately improve recruitment and reduce costs associated with clinical trials. Peer-reviewed results demonstrating the human-level performance of this innovative system were presented to the pharmaceutical and clinical trials industry community at the prestigious European Crohn's and Colitis (ECCO) conference this week.

Key Points: 
  • Innovative, human-level AI technology will improve efficiency and consistency of Inflammatory Bowel Disease (IBD) scoring, advancing clinical trials of novel treatments for these debilitating ailments.
  • Inflammatory bowel diseases (IBD) such as Ulcerative Colitis (UC) and Crohn's disease are mostly diagnosed by performing a colonoscopy.
  • Algorithm performance, as assessed by the Kappa metric, was found to be comparable to the performance of human reviewers.
  • Clario, GI Reviewers, and RSIP Vision continue to collaborate to bring the benefits of AI to all aspects of IBD clinical trials.

ALPINE ESPORTS SIGNS QANPLATFORM AS ITS OFFICIAL BLOCKCHAIN PARTNER TO SUPPORT FAN ENGAGEMENT, TEAM PERFORMANCE AND OPERATIONS

Retrieved on: 
Tuesday, February 28, 2023

ALPINE ESPORTS SIGNS QANPLATFORM AS ITS OFFICIAL BLOCKCHAIN PARTNER TO SUPPORT FAN ENGAGEMENT, TEAM PERFORMANCE AND OPERATIONS

Key Points: 
  • ALPINE ESPORTS SIGNS QANPLATFORM AS ITS OFFICIAL BLOCKCHAIN PARTNER TO SUPPORT FAN ENGAGEMENT, TEAM PERFORMANCE AND OPERATIONS
    The issuer is solely responsible for the content of this announcement.
  • For Alpine Esports the partnership will aid the team's fan engagement strategy and allow them to create practical use cases that will support internal operations.
  • QANplatform will become the Official Blockchain Partner of Alpine Esports where besides the use cases, QANplatform will take pride of place on the new F1 Esports team jersey and esport cars next to other partners like Binance, Kappa, and Shamir.
  • Alpine Esports invested in Web3 activations in 2022, playing a pivotal role in their fan engagement strategy with the launch of the Alpine Esports Series which saw them offer $100k worth Alpine Fan Tokens.

Balchem Corporation Reports Fourth Quarter Net Sales Growth of 9.1% and Strong Full Year 2022 Results

Retrieved on: 
Friday, February 24, 2023

Financial Results for the Fourth Quarter of 2022:

Key Points: 
  • Financial Results for the Fourth Quarter of 2022:
    The Human Nutrition & Health segment generated fourth quarter sales of $130.4 million, an increase of $14.9 million or 12.9% compared to the prior year quarter.
  • Fourth quarter earnings from operations for this segment were $17.5 million for both 2022 and 2021.
  • The Animal Nutrition & Health segment generated quarterly sales of $64.8 million, a decrease of $0.2 million or 0.3% compared to the prior year quarter.
  • Interest expense was $5.1 million and $0.6 million in the fourth quarter of 2022 and 2021, respectively.

LexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract Infections

Retrieved on: 
Wednesday, July 27, 2022

Each site operated a MiQLab System equipped with a MiQLab Bacterial and AMR Test V2 , which screens samples for 10 common pathogens and 33 markers for antimicrobial resistance factors.

Key Points: 
  • Each site operated a MiQLab System equipped with a MiQLab Bacterial and AMR Test V2 , which screens samples for 10 common pathogens and 33 markers for antimicrobial resistance factors.
  • A total of 105 urine specimens were tested across the two sites, of which, 39 were deemed to be clinically relevant for a urinary tract infection.
  • The MiQLab System successfully detected all Escherichia coli, Staphylococcus, Proteus, Klebsiella, Enterococcus faecium, and Enterococcus faecalis positive samples.
  • LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of pathogens and other molecular markers.